Medicare Enrolled

Dr. Shruti Shah, MD

Pain Medicine · Holmdel, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
670 N BEERS ST STE 4, Holmdel, NJ 07733
7326656492
In practice since 2009 (16 years)
NPI: 1114158755 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Shah from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shah? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Shah

Dr. Shruti Shah is a pain medicine specialist in Holmdel, NJ, with 16 years of NPI registration. Based on federal Medicare data, Dr. Shah performed 1,867 Medicare services across 738 unique beneficiaries.

Between the years covered by Open Payments, Dr. Shah received a total of $4,437 from 34 pharmaceutical and/or device companies across 134 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Shah is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice ▲ Top 21% volume in NJ $4,437 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,867
Medicare services
Top 21% in NJ for pain medicine
738
Unique beneficiaries
$96
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~117 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,056 $106 $192
Sacral spine nerve root injection with imaging guidance
An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement.
97 $94 $799
Additional sacral spine nerve root injection with imaging
An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging.
95 $44 $582
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
95 $75 $163
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
71 $140 $417
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement.
65 $113 $786
Facet joint injection, second level, with imaging guidance
An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated.
65 $63 $487
Injection, methylprednisolone acetate, 40 mg 63 $6 $49
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
49 $66 $175
Ultrasound-guided large joint aspiration or injection
This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint.
46 $85 $305
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
35 $108 $300
Facet joint nerve destruction, single joint
A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals.
31 $161 $1,000
Facet joint nerve destruction, additional joint
This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint.
31 $49 $400
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement.
20 $126 $601
Facet joint injection, second level, with imaging
An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement.
20 $74 $490
Spinal nerve root injection with imaging guidance
An injection of anesthetic or steroid medication into a single nerve root in the upper or middle spine. The procedure uses imaging guidance to ensure accurate placement.
15 $109 $500
Additional spine nerve root injection with imaging
An anesthetic and/or steroid medication is injected into an additional nerve root in the upper or middle spine. The procedure uses imaging guidance to ensure accurate placement.
13 $51 $500
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,437
Total received (2018-2024)
Avg $634/year across 7 years
Top 22% in NJ for pain medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
134
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,437 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,389
2023
$516
2022
$851
2021
$739
2020
$88
2019
$583
2018
$271

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Curonix LLC
$606
BIOTRONIK NRO, Inc.
$170
SPR Therapeutics, Inc
$161
Averitas Pharma Inc.
$92
SCILEX PHARMACEUTICALS INC.
$91
Boston Scientific Corporation
$60
Nalu Medical, Inc.
$52
Abbott Laboratories
$48
DePuy Synthes Sales Inc.
$30
Nevro Corp.
$22
Medtronic, Inc.
$21
Bioventus LLC
$19
Saluda Medical Americas, Inc.
$18
Top 3 companies account for 67.4% of 2024 payments
All-time payments by company (2018-2024) ›
SPR Therapeutics, Inc
$792
Curonix LLC
$626
SI-BONE, Inc.
$553
Medtronic, Inc.
$318
Medtronic USA, Inc.
$285
Boston Scientific Corporation
$202
Kowa Pharmaceuticals America, Inc.
$199
SI-BONE, INC.
$173
BIOTRONIK NRO, Inc.
$170
Nevro Corp.
$147
SCILEX PHARMACEUTICALS INC.
$135
Scilex Pharmaceuticals Inc.
$121
Averitas Pharma Inc.
$92
Vertos Medical, Inc.
$69
NuVasive, Inc.
$67
BOSTON SCIENTIFIC CORPORATION
$52
Nalu Medical, Inc.
$52
Abbott Laboratories
$48
Novo Nordisk Inc
$41
Bioventus LLC
$36
DePuy Synthes Sales Inc.
$30
Merck Sharp & Dohme Corporation
$27
Almatica Pharma LLC
$27
Janssen Pharmaceuticals, Inc
$24
Phadia US Inc.
$20
Saluda Medical Americas, Inc.
$18
Lucid Diagnostics Inc.
$16
Boehringer Ingelheim Pharmaceuticals, Inc.
$15
Astellas Pharma US Inc
$15
Biohaven Pharmaceutical Holding Company Ltd.
$15
AstraZeneca Pharmaceuticals LP
$15
Amgen Inc.
$15
IBSA Pharma Inc.
$14
Circassia Pharmaceuticals Inc
$11
Top 3 companies account for 44.4% of all-time payments
Associated products mentioned in payments ›
ADAPTIVESTIM · ALIF · AUTOFILL · Durolane · ELYXYB - CELECOXIB · ETERNA · Evoke · FASENRA · GENERAL PAIN MANAGEMENT · General - Pain Management · IFUSE IMPLANT · INTELLIS · INTELLIS ADAPTIVESTIM · ImmunoCAP · JANUVIA · JARDIANCE · KYPHON EXPRESS II KYPHOPAK TRAY · LICART · Livalo · MYRBETRIQ · MYSTIM · NAPRELAN · NURTEC ODT · Nalu Neurostimulation System · OCTRODE · ORTHOVISC · Ozempic · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PROCLAIM · Prospera · QUTENZA · Repatha · Rybelsus · SEGLENTIS · SPECTRA WAVEWRITER · SPRINT PNS System · SUPARTZ FX SODIUM HYALURONATE · Senza · Senza Spinal Cord Stimulation System · TUDORZA PRESSAIR · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XARELTO · ZTLido · iFuse Implant · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pain medicine specialist in Holmdel?
Compare pain medicines in the Holmdel area by procedure volume, costs, and industry payment transparency.
Browse pain medicines nearby

Geographic Context

Pain medicines within 10 mi
83
Per 100K population
12.9
County median income
$122,727
Nearest hospital
BAYSHORE MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Shah is a clinical cardiology specialist, with above-average Medicare volume (top 21% in NJ), with low-engagement industry engagement, with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Shah experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Shah performed 1,056 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shah receive payments from pharmaceutical companies?
Yes. Dr. Shah received a total of $4,437 from 34 companies across 134 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shah's costs compare to other pain medicines in Holmdel?
Dr. Shah's average Medicare payment per service is $96. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shah) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →